{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:28:36Z","timestamp":1789075716634,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Hubei Province Key Laboratory of Molecular Imaging, Grant","award":["2021fzyx008"],"award-info":[{"award-number":["2021fzyx008"]}]},{"name":"Hubei Province Key Laboratory of Molecular Imaging, Grant","award":["2021fzyx008"],"award-info":[{"award-number":["2021fzyx008"]}]},{"name":"Hubei Province Key Laboratory of Molecular Imaging, Grant","award":["2021fzyx008"],"award-info":[{"award-number":["2021fzyx008"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102168 and 81873919"],"award-info":[{"award-number":["82102168 and 81873919"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102168 and 81873919"],"award-info":[{"award-number":["82102168 and 81873919"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The purpose of this study was to evaluate the therapeutic efficacy and safety of endovascular treatment aorto-iliac occlusive disease (AIOD) with TransAtlantic Inter-Society Consensus II (TASC II) C and D lesions. In addition, 10\u00a0years of experience with interventional procedures and treatment options in our center were also worthy of further discussion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Between January 2011 and December 2020, a total of 26 consecutive AIOD patients with TASC-II C and D lesions treated endovascular approach were enrolled in this study. Patients' demographic and clinical data were collected, and the safety and efficacy of endovascular therapy were evaluated. In addition, operation procedures were also described.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The mean age of patients was 62.2\u2009\u00b1\u20097\u00a0years (49\u201357\u00a0years), and the mean body mass index of patients was 24.2\u2009\u00b1\u20092.6\u00a0kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      . Fifteen patients (57.7%) were Rutherford 4, 5 each (19.2%) were Rutherford 3 and 5, and 1 (3.8%) was Rutherford 2. No other serious complications occurred except death in 3 patients. Most of the patients (73.1%) had a history of smoking, and hypertension and hyperlipidemia were common comorbidities. Endovascular therapy was successfully performed in 25 patients, and the technical success rate was 96.2%. The patient's ankle-brachial index improved significantly postoperatively compared with preoperatively (preoperative 0.33\u2009\u00b1\u20090.14 vs 1.0\u2009\u00b1\u20090.09,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). The primary patency rates were 100%, 95.7%, and 91.3% at 1, 3, and 5\u00a0years, while the secondary patency rates were 100%. No treatment-related deaths or serious complications occurred.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Endovascular treatment of AIOD patients with TASC-II C and D lesions might be safe and have a high rate of middle-term and long-term primary patency.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-023-03059-4","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:02:56Z","timestamp":1675728176000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Endovascular treatment of aorto-iliac occlusive disease with TASC II C and D lesions: 10\u00a0year\u2019s experience of clinical technique"],"prefix":"10.1186","volume":"23","author":[{"given":"Xiangjun","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqian","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqiao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangbo","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuansheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,7]]},"reference":[{"key":"3059_CR1","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1016\/j.jvs.2018.01.067","volume":"68","author":"G Sharma","year":"2018","unstructured":"Sharma G, Scully RE, Shah SK, et al. Thirty-year trends in aortofemoral bypass for aortoiliac occlusive disease. J Vasc Surg. 2018;68:1796-1804.e2.","journal-title":"J Vasc Surg"},{"issue":"1","key":"3059_CR2","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.asjsur.2019.02.002","volume":"43","author":"C Quan","year":"2020","unstructured":"Quan C, Kim DH, Jung HJ, Lee SS. Comparison of results between kissing stent and aortic bifurcated bypass in aortoiliac occlusive disease. Asian J Surg. 2020;43(1):186\u201392.","journal-title":"Asian J Surg"},{"key":"3059_CR3","doi-asserted-by":"crossref","unstructured":"Upchurch GR, Dimick JB, Wainess RM, et al. Diffusion of new technology in health care: the case of aorto-iliac occlusive disease. Surgery 2004; 136:812\u2013818.","DOI":"10.1016\/j.surg.2004.06.019"},{"issue":"Suppl 1","key":"3059_CR4","first-page":"S1","volume":"33","author":"L Norgren","year":"2007","unstructured":"Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;33(Suppl 1):S1-75.","journal-title":"J Vasc Surg"},{"key":"3059_CR5","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.jvs.2020.01.084","volume":"72","author":"BP Mwipatayi","year":"2020","unstructured":"Mwipatayi BP, Ouriel K, Anwari T, et al. A systematic review of covered balloon-expandable stents for treating aortoiliac occlusive disease. J Vasc Surg. 2020;72:1473-1486.e2.","journal-title":"J Vasc Surg"},{"key":"3059_CR6","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.avsg.2020.04.055","volume":"68","author":"C Shen","year":"2020","unstructured":"Shen C, Zhang Y, Qu C, et al. Outcomes of total aortoiliac revascularization for TASC-II C&D lesion with kissing self-expanding covered stents. Ann Vasc Surg. 2020;68:434\u201341.","journal-title":"Ann Vasc Surg"},{"key":"3059_CR7","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.avsg.2018.07.060","volume":"56","author":"UM Bracale","year":"2019","unstructured":"Bracale UM, Giribono AM, Spinelli D, et al. Long-term results of endovascular treatment of TASC C and D aortoiliac occlusive disease with expanded polytetrafluoroethylene stent graft. Ann Vasc Surg. 2019;56:254\u201360.","journal-title":"Ann Vasc Surg"},{"issue":"10","key":"3059_CR8","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1007\/s00270-021-02785-6","volume":"44","author":"M Salem","year":"2021","unstructured":"Salem M, et al. Management of extensive aorto-iliac disease: a systematic review and meta-analysis of 9319 patients. Cardiovasc Intervent Radiol. 2021;44(10):1518\u201335.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"3059_CR9","first-page":"2851","volume":"71","author":"V Aboyans","year":"2017","unstructured":"Aboyans V, Ricco JB, Bartelink MLEL, et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur Heart J. 2017;71:2851\u2013906.","journal-title":"Eur Heart J"},{"key":"3059_CR10","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0741-5214(97)70045-4","volume":"26","author":"RB Rutherford","year":"1997","unstructured":"Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26:517\u201338.","journal-title":"J Vasc Surg"},{"key":"3059_CR11","unstructured":"Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC working group. TransAtlantic inter-society consensus (TASC). J Vasc Surg 2000; 31:S1-S296."},{"key":"3059_CR12","doi-asserted-by":"publisher","first-page":"S199","DOI":"10.1097\/01.RVI.0000094584.83406.3e","volume":"14","author":"D Sacks","year":"2003","unstructured":"Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol. 2003;14:S199-202.","journal-title":"J Vasc Interv Radiol"},{"key":"3059_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jvs.2016.06.107","volume":"65","author":"W Dorigo","year":"2017","unstructured":"Dorigo W, Piffaretti G, Benedetto F, et al. A comparison between aortobifemoral bypass and aortoiliac kissing stents in patients with complex aortoiliac obstructive disease. J Vasc Surg. 2017;65:99\u2013107.","journal-title":"J Vasc Surg"},{"issue":"11","key":"3059_CR14","doi-asserted-by":"publisher","first-page":"989","DOI":"10.5551\/jat.45617","volume":"26","author":"K Nanto","year":"2019","unstructured":"Nanto K, Iida O, Fujihara M, et al. Five-year patency and its predictors after endovascular therapy for aortoiliac occlusive disease. J Atheroscler Thromb. 2019;26(11):989\u201396.","journal-title":"J Atheroscler Thromb"},{"key":"3059_CR15","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1583\/JEVT-12-3941MR.1","volume":"19","author":"FA Grimme","year":"2012","unstructured":"Grimme FA, Spithoven JH, Zeebregts CJ, et al. Midterm outcome of balloon-expandable polytetrafluoroethylene-covered stents in the treatment of iliac artery chronic occlusive disease. J Endovasc Ther. 2012;19:797\u2013804.","journal-title":"J Endovasc Ther"},{"key":"3059_CR16","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.ejvs.2015.06.112","volume":"50","author":"FA Grimme","year":"2015","unstructured":"Grimme FA, Goverde PC, Verbruggen PJ, et al. Editor\u2019s choice-first results of the covered endovascular reconstruction of the aortic bifurcation (CERAB) technique for aortoiliac occlusive disease. Eur J Vasc Endovasc Surg. 2015;50:638\u201347.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"3059_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.avsg.2020.05.043","volume":"68","author":"J Manunga","year":"2020","unstructured":"Manunga J, Mirza A, Skeik N, et al. Comparative long-term outcomes of patients with aortoiliac occlusive disease limited to common iliac arteries who underwent endarterectomy versus bypass grafting. Ann Vasc Surg. 2020;68:1\u20137.","journal-title":"Ann Vasc Surg"},{"key":"3059_CR18","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.jvs.2012.09.038","volume":"57","author":"GR Sachwani","year":"2013","unstructured":"Sachwani GR, Hans SS, Khoury MD, et al. Results of iliac stenting and aortofemoral grafting for iliac artery occlusions. J Vasc Surg. 2013;57:1030\u20137.","journal-title":"J Vasc Surg"},{"key":"3059_CR19","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.jvs.2008.07.004","volume":"48","author":"VS Kashyap","year":"2008","unstructured":"Kashyap VS, Pavkov ML, Bena JF, et al. The management of severe aortoiliac occlusive disease: endovascular therapy rivals open reconstruction. J Vasc Surg. 2008;48:1451\u20137.","journal-title":"J Vasc Surg"},{"key":"3059_CR20","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jvs.2010.08.073","volume":"53","author":"BL Chen","year":"2011","unstructured":"Chen BL, Holt HR, Day JD, et al. Subintimal angioplasty of chronic total occlusion in iliac arteries: a safe and durable option. J Vasc Surg. 2011;53:367\u201373.","journal-title":"J Vasc Surg"},{"key":"3059_CR21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/1538574413512381","volume":"48","author":"M Taurino","year":"2014","unstructured":"Taurino M, Persiani F, Fantozzi C, et al. Trans-atlantic inter-society consensus II C and D iliac lesions can be treated byendovascular andhybridapproach: a singlecenter experience. Vasc Endovascular Surg. 2014;48:123\u20138.","journal-title":"Vasc Endovascular Surg"},{"key":"3059_CR22","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.ejvs.2008.06.027","volume":"36","author":"K Bjorses","year":"2008","unstructured":"Bjorses K, Ivancev K, Riva L, et al. Kissing stents in the aortic bifurcationda valid reconstruction for aortoiliac occlusive disease. Eur J Vasc Endovasc Surg. 2008;36:424\u201331.","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"3","key":"3059_CR23","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/S0741-5214(03)00886-3","volume":"38","author":"AT Ali","year":"2003","unstructured":"Ali AT, et al. Emerging role of endovascular grafts in complex aortoiliac occlusive disease. J Vasc Surg. 2003;38(3):486\u201391.","journal-title":"J Vasc Surg"},{"issue":"2","key":"3059_CR24","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/00015458.2006.11679868","volume":"106","author":"A De Roeck","year":"2016","unstructured":"De Roeck A, et al. Long-term results of primary stenting for long and complex iliac artery occlusions. Acta Chir Belg. 2016;106(2):187\u201392.","journal-title":"Acta Chir Belg"},{"issue":"2","key":"3059_CR25","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1053\/ejvs.2002.1882","volume":"26","author":"A Greiner","year":"2003","unstructured":"Greiner A, et al. Kissing stents for treatment of complex aortoiliac disease. Eur J Vasc Endovasc Surg. 2003;26(2):161\u20135.","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"3059_CR26","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.avsg.2018.06.002","volume":"53","author":"T Inui","year":"2018","unstructured":"Inui T, et al. External iliac occlusion does not preclude endovascular management of aortoiliac disease-technique and evolution of therapy. Ann Vasc Surg. 2018;53:184\u20139.","journal-title":"Ann Vasc Surg"},{"issue":"7","key":"3059_CR27","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1007\/s11547-006-0093-5","volume":"111","author":"D Lagana","year":"2006","unstructured":"Lagana D, et al. Endovascular treatment of steno-occlusions of the infrarenal abdominal aorta. Radiol Med. 2006;111(7):949\u201358.","journal-title":"Radiol Med"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03059-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-023-03059-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03059-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:05:49Z","timestamp":1675728349000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-023-03059-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,7]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3059"],"URL":"https:\/\/doi.org\/10.1186\/s12872-023-03059-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2145055\/v1","asserted-by":"object"}]},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,7]]},"assertion":[{"value":"8 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the institutional review board of the Union Hospital, Tongji Medical college, Huazhong University of Science and Technology. Writtern informed consent was waived for this retrospective study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"71"}}